eribulin mesylate
Generic: eribulin mesylate
Labeler: apotex corp.Drug Facts
Product Profile
Brand Name
eribulin mesylate
Generic Name
eribulin mesylate
Labeler
apotex corp.
Dosage Form
INJECTION
Routes
Active Ingredients
eribulin mesylate .5 mg/mL
Manufacturer
Identifiers & Regulatory
Product NDC
60505-6435
Product ID
60505-6435_69c87b29-2670-aa40-b36a-40df421adb14
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA218047
Listing Expiration
2026-12-31
Marketing Start
2025-03-19
Pharmacologic Class
Classes
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
605056435
Hyphenated Format
60505-6435
Supplemental Identifiers
RxCUI
UNII
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
eribulin mesylate (source: ndc)
Generic Name
eribulin mesylate (source: ndc)
Application Number
ANDA218047 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- .5 mg/mL
Packaging
- 1 VIAL, SINGLE-DOSE in 1 CARTON (60505-6435-0) / 2 mL in 1 VIAL, SINGLE-DOSE
Packages (1)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["INTRAVENOUS"], "spl_id": "69c87b29-2670-aa40-b36a-40df421adb14", "openfda": {"unii": ["AV9U0660CW"], "rxcui": ["1045456"], "spl_set_id": ["64bf3c30-f06a-3615-ca5e-eb4154d371d0"], "manufacturer_name": ["Apotex Corp."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL, SINGLE-DOSE in 1 CARTON (60505-6435-0) / 2 mL in 1 VIAL, SINGLE-DOSE", "package_ndc": "60505-6435-0", "marketing_start_date": "20250319"}], "brand_name": "eribulin mesylate", "product_id": "60505-6435_69c87b29-2670-aa40-b36a-40df421adb14", "dosage_form": "INJECTION", "pharm_class": ["Microtubule Inhibition [PE]", "Microtubule Inhibitor [EPC]"], "product_ndc": "60505-6435", "generic_name": "eribulin mesylate", "labeler_name": "Apotex Corp.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "eribulin mesylate", "active_ingredients": [{"name": "ERIBULIN MESYLATE", "strength": ".5 mg/mL"}], "application_number": "ANDA218047", "marketing_category": "ANDA", "marketing_start_date": "20250319", "listing_expiration_date": "20261231"}